JPMorgan Chase & Co. Reiterates “Hold” Rating for CME Group (CME)
CME Group (NYSE:CME)‘s stock had its “hold” rating restated by analysts at JPMorgan Chase & Co. in a research report issued to clients and investors on Tuesday. They currently have a $67.50 price target on the stock, down from their previous price target of $69.50. JPMorgan Chase & Co.’s price target points to a potential downside of 4.40% from the stock’s previous close.
In other CME Group news, CEO Phupinder Gill sold 49,000 shares of CME Group stock on the open market in a transaction dated Monday, June 2nd. The stock was sold at an average price of $71.66, for a total value of $3,511,340.00. The transaction was disclosed in a filing with the SEC, which is available at this link.
CME Group (NYSE:CME) traded down 0.82% during mid-day trading on Tuesday, hitting $70.03. The stock had a trading volume of 1,274,134 shares. CME Group has a one year low of $66.44 and a one year high of $84.71. The stock has a 50-day moving average of $70.42 and a 200-day moving average of $74.66. The company has a market cap of $23.516 billion and a P/E ratio of 23.54.
CME Group (NYSE:CME) last announced its earnings results on Thursday, May 1st. The company reported $0.83 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.83. The company had revenue of $777.00 million for the quarter, compared to the consensus estimate of $368.13 million. During the same quarter in the previous year, the company posted $0.73 earnings per share. The company’s revenue for the quarter was up 8.1% on a year-over-year basis. On average, analysts predict that CME Group will post $3.33 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Wednesday, June 25th. Stockholders of record on Tuesday, June 10th will be paid a dividend of $0.47 per share. This represents a $1.88 annualized dividend and a dividend yield of 2.66%. The ex-dividend date is Friday, June 6th.
Several other analysts have also recently commented on the stock. Analysts at Zacks downgraded shares of CME Group from a “neutral” rating to an “underperform” rating in a research note on Monday. They now have a $63.00 price target on the stock. Separately, analysts at Jefferies Group reiterated a “buy” rating on shares of CME Group in a research note on Friday, May 9th. They now have a $84.00 price target on the stock, down previously from $89.00. Finally, analysts at Barclays reiterated an “equal weight” rating on shares of CME Group in a research note on Friday, May 2nd. They now have a $78.00 price target on the stock. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and seven have issued a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $77.18.
CME Group Inc (NYSE:CME) offer a range of global products across all asset classes based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, metals, weather and real estate.
Receive News & Ratings for CME Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.